Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04794543 · ClinicalTrials.gov registry record
Effects of Using E-Cigarettes on Lungs in People With HIV (HBS Ancillary)
A clinical trial of HIV and Lung Injury, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 23
- Enrollment target
- 2
- Study locations
NCT04794543: Completed study of HIV and Lung Injury, sponsored by Pennington Biomedical Research Center.
NCT04794543 is a study of HIV and Lung Injury that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 23 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04794543, a study of HIV and Lung Injury, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is an ancillary study, thus participants will be recruited from participants in the HBS Study. This project acutely assesses the role of the e-cigarettes and vaping on lung health. The proposed work will inform the design of future studies to better understand vaping's health consequences and to test novel interventions to mitigate vaping's contribution to acute and/or chronic lung injury.
Primary Outcome
Metabolomic analyses of exhaled breath condensate and gas.
Conditions Studied
Study Locations (2)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
- Lsuhsc-No - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2023-12-04 |
What the finished NCT04794543 record still lists
NCT04794543 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 440-participant average among 303 other HIV trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with HIV appearing as the primary indexed condition, and to 0 interventions.
NCT04794543 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT04794543 about?
NCT04794543 is a clinical study titled "Effects of Using E-Cigarettes on Lungs in People With HIV (HBS Ancillary)". This is an ancillary study, thus participants will be recruited from participants in the HBS Study. This project acutely assesses the role of the e-cigarettes and vaping on lung health. The proposed work will inform the design of future studies to better understand vaping's health consequences and t...
What is the current status of trial NCT04794543?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2022-04-01. Estimated completion is 2023-12-04.
What conditions does trial NCT04794543 study?
This clinical trial studies the following conditions: HIV, Lung Injury.
Who is sponsoring clinical trial NCT04794543?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04794543 being conducted?
This trial has 2 study locations across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04794543's enrollment target sits among peer trials
23 282nd of 303 higher than 22 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transitional Housing and HIV Health
RECRUITING
-
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
RECRUITING · Phase 1
-
Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
RECRUITING
-
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
RECRUITING · Phase 2
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI